跳至主要内容
临床试验/NCT01187823
NCT01187823已完成不适用

Comparison of Adaptive Servo Ventilation(Bipap® Auto SV Advanced) and Oxgen Therapy in Chronic Heart Failure Patients Complicated With Central Sleep Apnea

Kyoto University, Graduate School of Medicine2 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2010年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
2
主要终点
Left ventricular ejection fraction confirmed by echocardiography

研究概览

简要总结

The aim of this study is to compare the effects of Adaptive Servo Ventilation (Bipap® auto SV Advanced) and oxygen therapy in chronic heart failure patients complicated with central sleep apnea.

详细描述

Central sleep apnea(CSA) is associated with chronic heart failure(CHF). At present, both of nocturnal oxygen therapy and adaptive servo ventilation(ASV) are recognized as effective modalities. However,in fact, majority of CHF patients are complicated not only with CSA but with obstructive sleep apnea(OSA). Recently, Philips developed Bipap® auto SV Advanced for such patients. It has auto-CPAP function as the modality of OSAS, in addition to ASV function. The present study is prospective randomised study to compare the effects of nocturnal oxygen therapy and Bipap® auto SV Advanced.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Left ventricular ejection fraction<50% confirmed by echocardiography
  • Apnea hypopnea index(AHI)>=20 confirmed by overnight polysomnography
  • More than 15% of AHI is due to CSA

排除标准

  • Changes of cardioactive drug prescriptions within 6 weeks
  • Admission due to cardiovascular events within 6 weeks
  • Ever used CPAP or ASV for sleep apnea
  • Ever used nocturnal oxgen therapy
  • Subjects with acute exacerbation of chronic heart failure
  • Operation for upper airway within 90 days
  • Renal dialysis
  • History of stroke with neurological deficit

结局指标

主要结局

Left ventricular ejection fraction confirmed by echocardiography

时间窗: three months

次要结局

  • Blood pressure(three months)
  • Heart rate(three months)
  • Urinary biomarkers(three months)
  • Serum biomarkers(three months)
  • Sleep quality confirmed by polysomnography(three months)
  • Endothelial function(three months)
  • Sleepiness(three months)
  • health-related quality of life(three months)

研究者

发起方
Kyoto University, Graduate School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kimihiko Murase

medical doctor

Kyoto University, Graduate School of Medicine

研究点 (2)

Loading locations...

相似试验